Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with child's grade A or B cirrhosis: A multivariate analysis of prognostic factors

Journal of Clinical Gastroenterology

Volumn 28, Issue 4, 1999, Pages 334-340

  Savastano, Sergio ^a   Miotto, Diego ^a   Casarrubea, Giuseppe ^a   Teso, Selina ^a   Chiesura Corona, Matteo ^a   Feltrin, Gian Pietro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Chemotherapeutic infusion; Cirrhosis; Hepatic arteries; Liver; Liver neoplasms; Therapeutic blockade

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; BILIRUBIN; EPIRUBICIN; GELATIN SPONGE; IODINATED POPPYSEED OIL; SPONGOSTAN;

ADULT; AGED; ARTERY CATHETERIZATION; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; CANCER CHEMOTHERAPY; CAUSE OF DEATH; DISEASE ASSOCIATION; FEMALE; FEMORAL ARTERY; HUMAN; HYPERBILIRUBINEMIA; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SURVIVAL RATE;

EID: 0033028465     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199906000-00010     Document Type: Article

References (34)

1. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. A comparison of Lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995;332:1256-61.
2. Bronowicki JP, Vetter D, Dumas F, et al. Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients. Cancer 1994;74:16-24.
3. Florio F, Nardella M, Balzano S, Caturelli E, Siena D, Cammisa M. Treatment of hepatocellular carcinoma: a single-center experience. Cardiovasc Intervent Radiol 1997;20:23-8.
4. Savastano S, Benvegnu L, Feltrin GP, Alberti A, Chiesura-Corona M, Miottu D. Transcatheter arterial embolisation versus no treatment in cirrhotic patients with hepatocellular carcinoma: a retrospective comparative study. Eur Radiol 1994;4:155-60.
5. Stefanini GF, Amorati P, Biselli M, et al. Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience. Cancer 1995;75:2427-37.
6. Colombo M, De Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991-325:675-80.
7. Farmer DG, Rosove MH, Snaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg 1994;219: 236-47.
8. Rasmussen I, Garden OJ. The management of liver cell cancer. Eur J Gastroenterol Hepatol 1996;8:861-7.
9. Livraghi T, Bolondi L, Buscarini L, et al. No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. J Hepatol 1995; 22:522-6.
10. Lencioni R, Pinto F, Armillotta N, et al. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience. Eur Radiol 1997;7:514-19.
11. Manesis EK, Giannoulis G, Zoumboulis P, Vafiadou I, Hadziyannis SJ. Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial. Hepatology 1995;21:1535-42.
12. Chao Y, Chan WK, Huang YS, et al. Phase II study of flutamide in the treatment of hepatocellular carcinoma. Cancer 1996;77:635-39.
13. Cheng AL, Chen YC, Yeh KH, Chuang SE, Chen BR, Chen DS. Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinoma. Cancer 1996;77:872-7.
14. Liver Study Cancer Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. Jpn J Surg 1989;19:98-129.
15. Itai Y, Ohtomo K, Kokubo T, et al. CT of hepatic masses: significance of prolonged and delayed enhancement. AJR Am J Roentgenol 1986;146:729-33.
16. Stevens WR, Johnson CD, Stephens D, Batts KP. CT findings in hepatocellular carcinoma: correlation of tumor characteristics with causative factors, tumor size, and histologic tumor grade Radiology 1994;191:531-7.
17. Bismuth H, Samuel D, Engerran L Treatment of unresectable hepatocellular carcinoma [letter]. N Engl J Med 1995;333:878.
18. Yamamoto K, Masuzawa M, Kato M, Okuyama T, Tamura K. Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization. Cancer Chemother Pharmacol 1992;31(Suppl 1):S77-81.
19. Hsieh MY, Chang WY, Wang LY, et al. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors. Cancer Chemother Pharmacol 1992;31(Suppl 1):S82-5.
20. Mondazzi L, Bottelli R, Brambilla G, et al. Transcatheter oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology 1994;19: 1115-23.
21. Merkel C, Bolognesi M, Bellon S, et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology 1992;102:973-9.
22. Armonis A, Patch D, Burroughs A. Hepatic venous pressure measurement: an old test as a new prognostic marker in cirrhosis? Hepatology 1997;25:245-8.
23. Hatanaka Y, Yamashita Y, Takahashi M, et al. Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management. Radiology 1995;195:747-52.
24. Savastano S, Feltrin GP, Miotto D, Chiesura-Corona M, Casarrubea G, Cecchetto A. La chemioembolizzazione preoperatoria dell'epatocarcinoma su cirrosi. Radiol Med 1994;88:620-4.
25. Nagao T, Goto S, Kawano N, et al. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis Ann Surg 1987;205:33-40.
26. Huppert PE, Lauchart W, Torkler C, et al. Repetitive chemoembolization of HCC: analysis of prognostic factors [abstract]. Cardiovasc Intervent Radiol 1997;20(Suppl 1):51.
27. Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994;74:772-80.
28. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996;77:2217-22.
29. Trevisani F, D'Intino PE, Caraceni P, et al. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients. Cancer 1995;75: 2220-32.
30. Chung JW, Park JH, Han JK, et al. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembohzation. Radiology 1996;198:33-40.
31. Bianco S, Merkel C, Savastano S, et al. Short term effects of transcatheter arterial chemoembolisation on metabolic activity of the liver of cirrhotic patients with hepatocellular carcinoma. Gut 1996;39:325-9.
32. Taourel P, Dauzat M, Lafortune M, Pradel J, Rossi M, Bruel JM. Hemodynamic changes after transcatheter arterial embolization of hepatocellular carcinoma. Radiology 1994;191:189-92.
33. Jaeger JH, Mehring UM, Castañeda F, et al. Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma. Cardiovasc Intervent Radiol 1996;19:388-96.
34. Stuart K, Stokes K, Jenkins R, Trey C, Clouse M. Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization. Cancer 1993;72:3202-9.